Streetbeat News

INVO

INVO Bioscience, Inc.

https://www.invobio.com

Industry

Medical - Devices

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Open

0.86

Mkt cap

3.3M

Volume

124K

High

0.88

P/E Ratio

1.21

52-wk high

3.50

Low

0.82

Div yield

N/A

52-wk low

0.63

U.S. stocks traded higher with the Dow Jones gaining around 400 points. The NASDAQ surged 2.03% and the S&P 500 rose 1.61%. U.S. annual inflation rate slowed to 3.2% in October, below market estimates. BioCardia, Inc. soared 243% after FDA approval for a clinical trial. INVO Bioscience and Theseus Pharmaceuticals also saw significant gains. The Beauty Health Company, Kubient, Inc., and Applied UV faced sharp declines after negative reports. Oil and gold prices increased, while European and Asian markets showed mixed results.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 2:50 pm

Theseus Pharmaceuticals (THRX) is exploring strategic alternatives, causing its stock to surge by 53%. BioCardia (BCDA) announced FDA approval for its Phase 3 clinical trial of CardiAMP cell therapy for ischemic heart failure, leading to a 166% stock increase. INVO BioScience (INVO) reported a smaller-than-expected GAAP EPS loss of $0.70, beating estimates by $0.17, but missed revenue targets by $0.96M, with a total revenue of $0.97M, resulting in a 51% stock jump.

Portfolio Pulse from ryanfaloona@benzinga.com

November 14, 2023 | 1:41 pm

In Tuesday's pre-market session, several healthcare stocks showed significant movement. BioCardia (BCDA) saw a substantial increase of 115.5% to $0.86, while BioXcel Therapeutics (BTAI) experienced a sharp decline of 37.9% to $3.42. Other notable gainers included Theseus Pharmaceuticals (THRX), INVO Bioscience (INVO), Genfit (GNFT), Redhill Biopharma (RDHL), and Biodexa Pharmaceuticals (BDRX). On the losing side, Harrow (HROW), Tenax Therapeutics (TENX), Akili (AKLI), Renalytix (RNLX), and TRACON Pharma (TCON) saw their stock prices fall. The movements were largely attributed to recent earnings reports.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:06 pm

INVO Bioscience, Inc. (NASDAQ:INVO) shares increased by over 31% in pre-market trading due to a narrower Q3 loss and a 314% surge in quarterly sales. Other stocks experienced pre-market movements, with notable gainers including TCRT, AIRE, HRYU, THRX, RDHL, ABSI, PXMD, ADN, OMIC, and losers such as SKIN, HROW, AUVI, AKLI, HTCR, PRSO, FSR, TCON, TENX, XAIR.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 12:41 pm

INVO Bioscience reported a significant improvement in Q3 with EPS losses decreasing to $(0.70) from $(4.20) YoY, and sales increasing by 314.28% to $974.89K from $235.32K YoY.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:13 pm

INVO BioScience, Inc. (NASDAQ:INVO) stock has surged over 140% in the last month and is continuing its upward momentum, with a nearly 40% increase over the past five days. The trading volume has significantly exceeded the 100-day average, with over 16.4 million shares traded in the session. The rise comes ahead of an expected Schedule TO filing related to an exchange offer for warrants, which is part of a proposed merger with NAYA Biosciences, Inc. The stock's float is 2.444 million shares, with a high short interest of 11.82%.

Portfolio Pulse from Erica Kollmann

November 13, 2023 | 6:18 pm

During Monday's intraday session, several healthcare stocks experienced significant movements. Tenax Therapeutics (TENX) saw a massive surge of 322.1%, while Tivic Health Systems (TIVC) and ZyVersa Therapeutics (ZVSA) also posted substantial gains. On the downside, TC BioPharm (TCBP), Aclaris Therapeutics (ACRS), and Mainz Biomed (MYNZ) faced steep declines. Verve Therapeutics (VERV), TRACON Pharma (TCON), and Alector (ALEC) also dropped notably, with recent Q3 earnings reports potentially influencing their stock performance.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 5:31 pm

Wynn Resorts, Limited (NASDAQ:WYNN) shares dropped by 8.1% despite reporting higher than expected third-quarter revenue and earnings per share. The company's revenue was $1.67 billion, surpassing the consensus estimate of $1.585 billion, and adjusted EPS was 99 cents, beating the estimate of 75 cents. The article also lists other stocks that moved in the mid-day session, with various companies experiencing significant gains or losses after reporting their financial results, guidance updates, or other corporate actions.

Portfolio Pulse from Lisa Levin

November 10, 2023 | 6:34 pm

INVO Bioscience Inc (NASDAQ:INVO) is experiencing a surge in stock price, trading over 100% higher, following its announcement of soliciting waivers from holders of common stock purchase warrants related to its upcoming merger with NAYA Biosciences Inc. The merger, agreed last month, is an all-stock deal where NAYA shareholders will receive 7.3333 INVO shares per NAYA share, totaling approximately 18.15 million INVO shares. Post-merger, the company will operate as NAYA Biosciences with Daniel Teper as Chairman and CEO. The waiver solicitation expires on November 15, 2023. INVO's stock volume soared to 49.8 million shares, significantly higher than the 100-day average of 1.81 million shares.

Portfolio Pulse from Vandana Singh

November 10, 2023 | 5:42 pm

Health care stocks experienced significant movement in Friday's intraday session. INVO Bioscience (INVO) saw a 115.4% increase, while Treace Medical Concepts (TMCI) dropped 44.3%. Earnings reports influenced many of the stock movements, with several companies releasing Q3 results recently.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.